XOMA (US) LLC Announces Presentation at Biotechnology Industry Organization (BIO) CEO and Investor Conference on February 9

BERKELEY, Calif., Feb. 3, 2010 (GLOBE NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, announced that Steven B. Engle, Chairman and Chief Executive Officer of XOMA, is scheduled to present at the 12th annual BIO CEO and Investor Conference on Tuesday, February 9, 2009 at 9:00 am Eastern time New York City.
MORE ON THIS TOPIC